ghk-cu peptide cancer What is GHK-Cu

Receptor-Target Mismatch GHK-Cu acts primarily on dermal fibroblasts and basal keratinocytes

Most skin types tolerate GHK-Cu well, though a patch test or professional skin assessment is always recommended before starting, particularly for sensitive or reactive skin

the exact amount depends on the concentration you want

12 mg subcutaneous daily , or 1 mg three times weekly , is the most commonly used GHK-Cu skin dose in published research and clinic practice

Understanding why your skin might temporarily worsen, how to distinguish normal adjustment from genuine adverse reactions, and when to modify your protocol versus when to push through can mean the difference between abandoning a potentially transformative compound and achieving the results you started this journey for

Conventional approaches to reactive skin include topical metronidazole, azelaic acid, oral antibiotics, and post-procedure corticosteroids